US' Food and Drug Administration (FDA) added a warning for Johnson & Johnson’s COVID-19 vaccine saying data suggests there's an increased risk of a rare neurological disorder in six weeks after inoculation. It added that chances of developing Guillain-Barré Syndrome are low but they appear to be 3-5 times higher among recipients of J&J vaccine than among general population.
विविध क्षेत्र
Johnson & Johnson COVID-19 vaccine increases risk of rare nerve disorder, warns US FDA

- 13 Jul 2021